微生物発酵技術の世界市場規模：製品タイプ別、用途別、地域別、範囲および予測

微生物発酵技術の市場規模と予測

微生物発酵技術の市場規模は、2024年に305億6,000万米ドルと評価され、2026年から2032年にかけてCAGR 5%で成長し、2032年には451億4,000万米ドルに達すると予測されます。

微生物発酵技術は、特定の環境条件下で細菌、酵母、真菌などの微生物を制御して開発し、価値ある商品を生産するものです。微生物の代謝能力を利用し、生化学反応を利用して原料を目的の分子に変換します。発酵は、微生物と望ましい結果に応じて、好気性（酸素あり）または嫌気性（酸素なし）のいずれかの条件下で行われます。この技術はもともと飲食品製造に利用されていたが、その後、医薬品、化学薬品、バイオ燃料、さらには生分解性プラスチックにまで発展しました。

この方法はさまざまな産業で幅広く使われています。ヨーグルト、チーズ、パンなどの発酵食品の製造において重要な役割を果たしています。製薬業界では、抗生物質、ワクチン、治療用タンパク質の製造に用いられます。化学産業における発酵は、有機酸、酵素、アミノ酸を生み出し、様々な製品に利用されています。

微生物発酵市場の大幅な拡大と革新。遺伝子工学と合成生物学の進歩は、微生物株を進化させ、特定の製品に最適化する能力を向上させ、生産と効率を高めています。持続可能な実践と循環型経済への移行は、特にバイオベース製品と再生可能エネルギー源のための微生物発酵のさらなる研究開発に拍車をかけると予想されます。

微生物発酵技術の世界市場力学

世界の微生物発酵技術市場を形成している主な市場力学

主な市場促進要因

バイオベース製品に対する需要の高まり微生物発酵技術市場は、持続可能な天然製品に対する顧客需要の高まりによって牽引されています。米国農務省の報告書によると、世界のバイオベース製品市場は2024年までに4,872億米ドルに達すると予測されています。

飲食品業界における採用の増加：微生物発酵は、特にプロバイオティクスや発酵食品の製造など、飲食品産業で広く採用されています。国際プロバイオティクス協会は、世界のプロバイオティクス市場が2023年までに693億米ドルに達し、2018年から2023年にかけてCAGR 7.0％で拡大すると予測しています。

製薬業界における用途の拡大：微生物発酵は、抗生物質や酵素などの医薬品の生産にますます使用されるようになっています。世界保健機関（WHO）によると、世界の抗生物質産業は2025年までに503億7,000万米ドル規模になると予想されており、発酵技術が生産高のかなりのシェアを占めています。

主な課題

プロセスの最適化とスケールアップ主な課題の一つは、生産性、純度、効率を最適化するための発酵操作の最適化です。実験室規模から工業規模への生産規模の拡大には、安定した環境条件の維持、無菌性の確保、発酵カイネティクスの制御といった技術的課題の解決が頻繁に必要となります。原料や微生物株のばらつきもスケールアップの妨げとなるため、多額の研究開発費が必要となります。

製品の多様化と市場の需要：新しい製品や用途に対する様々な市場ニーズに応えるには、継続的な技術革新と適応性が必要です。微生物発酵技術は、変化する顧客要求、科学的改善、環境目標に対応しなければならないです。新しい微生物株の開発、特定の製品に合わせた発酵条件の調整、従来の代替品と比較して優れた性能の実証はすべて、市場の妥当性と競争力を高めるための継続的な課題です。

技術統合とデジタル化：発酵プロセスを自動化、人工知能、ビッグデータ分析などのデジタル技術と統合することは、可能性と障害の両方を生み出します。デジタル化は工程管理、効率、製品品質を向上させるが、これらの技術をうまく統合するには、インフラ、経験、データ管理能力への多大な投資が必要となります。

主要動向：

バイオ医薬品の拡大：微生物発酵は、抗体、ワクチン、治療用タンパク質などのバイオ医薬品の生産にますます使用されるようになっています。遺伝子工学とバイオプロセスの最適化の進歩により、より高い収率と低価格で複雑な化合物を製造することが可能になり、バイオ医薬品分野での微生物発酵の利用を後押ししています。

持続可能なバイオベース製品の台頭：環境の持続可能性に対する意識の高まりが、市場をバイオベース製品へと押し上げています。微生物発酵は、再生可能な原料を生分解性ポリマー、バイオ燃料、グリーンケミカルに変換することにより、標準的な化学合成プロセスに代わる持続可能な代替手段を提供します。環境に優しい製品に対する消費者の嗜好や、バイオエコノミーの発展を促進する規制上のインセンティブが、この動向を後押ししています。

用途の多様化：微生物発酵は、食品や医薬品のような既成産業以外の新たな用途を見出しています。農業、化粧品、繊維、バイオエネルギー産業は、酵素、嗜好品、香料、生物農薬、バイオ肥料を生産するために、ますます微生物発酵に頼るようになっています。この多様性は、微生物発酵の多用途性と、産業界の要求に合わせて製品を調整する能力によって促進されています。

目次

第1章 世界の微生物発酵技術市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 微生物発酵技術の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 微生物発酵技術の世界市場：製品タイプ別

• 概要
• 酵素
• 抗生物質
• 有機酸
• ビタミン
• バイオポリマー

第6章 微生物発酵技術の世界市場：用途別

• 概要
• 医薬品
• 飲食品
• 農業
• 工業用化学品
• 環境保護

第7章 微生物発酵技術の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の微生物発酵技術市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• F. Hoffmann-La Roche AG
• Koninklijke DSM NV
• Lonza Group AG
• Novozymes A/S
• Danone Ltd.
• Amyris, Inc.
• Biocon Ltd.
• TerraVia Holdings, Inc.
• BioVectra Inc
• United Breweries Ltd

第10章 付録

• 関連調査

Microbial Fermentation Technology Market Size And Forecast

Microbial Fermentation Technology Market size was valued at USD 30.56 Billion in 2024 and is projected to reach USD 45.14 Billion by 2032, growing at a CAGR of 5% from 2026 to 2032.

Microbial fermentation technology is the controlled development of microorganisms such as bacteria, yeast, or fungi under specified environmental conditions to produce valuable goods. It uses the metabolic capabilities of these microorganisms to convert raw materials into desired molecules using biochemical reactions. Fermentation can take place in either aerobic (with oxygen) or anaerobic (without oxygen) conditions, depending on the microbe and desired result. This technology was originally utilized for food and beverage production, but it has since grown to include medications, chemicals, biofuels, and even biodegradable plastics.

This method is used extensively in a variety of industries. It plays an important role in the manufacture of fermented foods such as yogurt, cheese, and bread. In the pharmaceutical industry, it is used to create antibiotics, vaccines, and therapeutic proteins. Fermentation in the chemical industry yields organic acids, enzymes, and amino acids, which are employed in a variety of products.

Significant expansion and innovation in the microbial fermentation market. Advances in genetic engineering and synthetic biology are improving our ability to evolve and optimize microbial strains for specific products, hence increasing production and efficiency. The transition to sustainable practices and the circular economy is expected to spur additional research and development in microbial fermentation, particularly for bio-based products and renewable energy sources.

Global Microbial Fermentation Technology Market Dynamics

The key market dynamics that are shaping the global microbial fermentation technology market include:

Key Market Drivers:

Growing Demand for Bio-Based Products: The market for microbial fermentation technology is being driven by rising customer demand for sustainable and natural products. According to a US Department of Agriculture report, the global biobased goods market is predicted to reach $487.2 billion by 2024.

Rising Adoption in the Food and Beverage Industry: Microbial fermentation is widely employed in the food and beverage industry, particularly for the manufacture of probiotics and fermented meals. The International Probiotics Association predicts that the global probiotics market will reach $69.3 billion by 2023, expanding at a 7.0% CAGR between 2018 and 2023.

Expanding Applications in the Pharmaceutical Industry: Microbial fermentation is increasingly being used to produce medications such as antibiotics and enzymes. According to the World Health Organization, the worldwide antibiotics industry is expected to be worth $50.37 billion by 2025, with fermentation technologies accounting for a considerable share of output.

Key Challenges:

Process Optimization and Scale-up: One of the main issues is optimizing fermentation operations for optimal productivity, purity, and efficiency. Scaling up production from laboratory to industrial sizes frequently necessitates solving technical challenges such as maintaining stable ambient conditions, assuring sterility, and controlling fermentation kinetics. Variability in raw materials and microbial strains can also hamper scaling efforts, necessitating significant R&D costs.

Product Diversification and Market Demand: Meeting different market needs for new products and applications necessitates ongoing innovation and adaptability. Microbial fermentation technology must keep up with changing customer demands, scientific improvements, and environmental aims. Developing new microbial strains, adjusting fermentation conditions for specific products, and demonstrating superior performance relative to traditional alternatives are all continuous difficulties for market relevance and competitiveness.

Technological Integration and Digitalization: Integrating fermentation processes with digital technologies like automation, artificial intelligence, and big data analytics creates both potential and obstacles. While digitalization can improve process control, efficiency, and product quality, successfully integrating these technologies necessitates significant investment in infrastructure, experience, and data management capabilities.

Key Trends:

Expansion in Biopharmaceuticals: Microbial fermentation is increasingly being used to produce biopharmaceuticals such as antibodies, vaccines, and therapeutic proteins. Advances in genetic engineering and bioprocess optimization allow for the manufacture of complex compounds with higher yields and lower prices, which is boosting the use of microbial fermentation in the biopharmaceutical sector.

Rise of Sustainable and Bio-Based Products: The growing awareness of environmental sustainability is propelling the market toward bio-based products. Microbial fermentation provides a sustainable alternative to standard chemical synthesis processes by converting renewable feedstocks into biodegradable polymers, biofuels, and green chemicals. Consumer preferences for environmentally friendly products, as well as regulatory incentives to promote bioeconomy development, are driving this trend.

Application Diversification: Microbial fermentation is finding new uses outside of established industries like food and pharmaceuticals. Agriculture, cosmetics, textiles, and bioenergy industries are increasingly relying on microbial fermentation to produce enzymes, tastes, perfumes, biopesticides, and biofertilizers. This diversity is fueled by the versatility of microbial fermentation and its capacity to tailor products to suit industrial requirements.

Global Microbial Fermentation Technology Market Regional Analysis

Here is a more detailed regional analysis of the global microbial fermentation technology market:

Asia Pacific:

The Asia Pacific region currently holds the crown for the microbial fermentation technology market. According to UNESCAP, the Asia Pacific region's population is expected to expand rapidly, reaching 4.7 billion by 2050, producing strong demand across a variety of sectors that rely on fermentation technologies. The food and beverage market are primed for tremendous growth.

The region's huge and growing population has resulted in an increase in demand for food and drinks, pharmaceuticals, and industrial enzymes, all of which rely heavily on fermentation.

A growing number of Asian countries are developing as hubs for biopharmaceutical outsourcing, drawing both domestic and foreign firms. This, together with rising disposable income and greater investment in the food and beverage industry, drives the demand for sophisticated fermentation technology.

North America:

North America is expected to be the fastest expanding market for microbial fermentation technologies. North America is seeing a tremendous movement toward sustainable and environmentally friendly products, which is boosting the development of microbial fermentation technological advances. The US Department of Agriculture's bio-preferred program emphasizes the bio-based goods sector's significant economic impact, which contributed $459 billion to the US economy in 2016 and continues to grow.

The National Research Council of Canada predicts that the global market for bio-based chemicals will reach $85.6 billion by 2024, with North America serving as a key driver of this expansion. The findings highlight the region's vital function in developing bio-based solutions using microbial fermentation technologies.

North America leads the way in incorporating precise fermentation processes into food technology. According to the Good Food Institute, North American firms focused on fermentation-enabled alternative proteins raised $1.7 billion in funding in 2021.

The United States Department of Agriculture predicts that by 2030, the global market for alternative proteins, including those obtained from fermentation, will account for 10% of the entire protein industry, representing a $14 billion opportunity. These advancements emphasize North America's critical role in developing the use of precision fermentation to create sustainable and innovative food solutions.

Global Microbial Fermentation Technology Market: Segmentation Analysis

The Global Microbial Fermentation Technology Market is Segmented on the basis of Product Type, Application, And Geography.

Microbial Fermentation Technology Market Segmentation Analysis

Microbial Fermentation Technology Market, By Product Type

• Enzymes
• Antibiotics
• Organic Acids
• Vitamins
• Biopolymer

Based on Product Type, the market is bifurcated into Enzymes, Antibiotics, Organic Acids, Vitamins, and Biopolymers. Antibiotics dominate the microbial fermentation technology market due to established manufacturing methods and strong demand for these life-saving medications. However, the biopolymers segment is predicted to develop the fastest, owing to the growing emphasis on sustainability and the demand for environmentally acceptable alternatives to standard plastics.

Microbial Fermentation Technology Market, By Application

• Pharmaceuticals
• Food & Beverages
• Agriculture
• Industrial Chemicals
• Environmental

Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Agriculture, Industrial Chemicals, and Environmental. Due to the increasing demand for biopharmaceuticals such as antibiotics, vaccines, and other therapeutic proteins, the pharmaceutical segment now controls the majority of the microbial fermentation industry. However, the food and beverage industry is predicted to grow the fastest, thanks to the increased popularity of fermented goods such as yogurt and kombucha, as well as plant-based alternatives to meat and dairy.

Key Players

The "Global Microbial Fermentation Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza Group AG, Novozymes A/S, Danone Ltd., Amyris, Inc., Biocon Ltd., TerraVia Holdings, Inc., BioVectra, Inc., and United Breweries Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Microbial Fermentation Technology Market Recent Developments
• In May 2023, Danone Manifesto Ventures invested in Imagindairy, an Israeli start-up. Thus, the corporation purchased a minority investment in the precision fermentation company.
• In January 2023, BioZyme announced the launching of AO-Biotics. AO, a strain known for its great robustness, is used in the fermentation process by the company to create new fermentation products.
• In September 2022, Genetica, Cargill, and Cyclone Engineers partnered on a project to increase bioreactor fermentation capacity. The National Biotechnology and Biomanufacturing Initiative funded this research with USD 2.5 million.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Enzymes
• 5.3 Antibiotics
• 5.4 Organic Acids
• 5.5 Vitamins
• 5.6 Biopolymer

6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pharmaceuticals
• 6.3 Food & Beverages
• 6.4 Agriculture
• 6.5 Industrial Chemicals
• 6.6 Environmental

7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 F. Hoffmann-La Roche AG
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Koninklijke DSM NV
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Lonza Group AG
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Novozymes A/S
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Danone Ltd.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Amyris, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Biocon Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 TerraVia Holdings, Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 BioVectra Inc
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 United Breweries Ltd
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research